Stock Analysts' Upgrades for June 1st (APLT, ARHS, ASTS, ATHX, ATNM, ATTO, AURA, AVDX, BAK, BBLN)

Stock Analysts’ upgrades for Wednesday, June 1st: Applied Therapeutics (NASDAQ:APLT) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $1.50 target price on the stock. According to Zacks, “Applied Therapeutics Inc. is a clinical-stage biopharmaceutical company. It engages in developing drug candidates for unmet […]

Related Keywords

New York ,United States ,Japan ,Alagoas ,Maranhãbr ,Brazil ,Texas ,Bahia ,Luxembourg ,Rio Grande Do Sul ,Cambridge ,Cambridgeshire ,United Kingdom ,Ohio ,Spain ,Boston Heights ,America , ,Providence Acquisition Corp ,Aura Biosciences Inc ,Babylon Holdings ,Avidxchange Holdings Inc ,Zacks Investment Research ,Arhaus Inc ,Alkuri Global Acquisition Corp ,Therapeutics Inc ,Actinium Pharmaceuticals Inc ,Braskem ,Athersys Inc ,Actinium Pharmaceuticals ,Stock Analyst ,Diabetic Cardiomyopathy ,Investment Research ,New Providence Acquisition Corp ,Fast Track ,Breakthrough Therapy ,Antibody Radiation Conjugates ,Bone Marrow Transplant ,Gene Therapy ,Adoptive Cell Therapy ,Elderly Relapsed ,Refractory Acute Myeloid Leukemia ,Latin America ,Xchange Holdings ,Rio Grande ,Holdings Limited ,A Bear Workshop ,Applied Therapeutics Inc ,Ast Spacemobile Inc ,Atento Sa ,Braskem Sa ,Babylon Holdings Limited ,